Prevalence of Multidrug-Resistant Organisms in Hospital Samples: A Microbiology Lab Survey

Authors

  • Fawaz Atqan Almutairi
  • Faisal Saleh Alghamdi
  • Osama Munif Almutairi
  • Nader Faihan Alotaibi
  • Ahmed Faisal Al-Mutairi
  • Emtenan Hassan Linjawi

Keywords:

Multidrug-resistant organisms, surveillance, ICU, hospital infections, antibiotic resistance

Abstract

Background: Due to the significant clinical impact, the continuously growing amount of multidrug-resistant organisms (MDROs) continues to be problematic in hospital environments. The goal of this study is to understand the amount and contributing factors of MDROs found in clinical samples collected in hospitals.

Method: A total of five hundred clinical samples, collected from patients in all hospital divisions, were used. The antibiotic susceptibility patterns of the bacterial isolates were determined using standard microbiological methods. Multidrug resistance was quantified as resistance to at least one antimicrobial agent from three or more classes of the myriad of available antmicrobials. Using statistical methods, the relationship between the factors of interest and MDR was analyzed.

Results: Of the 470 samples yielding microbiological growth, 240 (51%) samples contained MDR organisms. The three most frequently isolated organisms were Escherichia coli (42%), Klebsiella pneumoniae (25%), and MRSA (12%). MDR infections were associated with previous antibiotic use (75%) and prolonged hospital stays (more than 7 days) (p < 0.05). The greatest frequency of MDR organisms was isolated from the ICU (42%).

Conclusion: The results of this study confirm that there is a high frequency of MDRO organisms in hospitals. The study confirms the relationship of previous antimicrobial use, prolonged hospital stays, and the frequency of MDR organisms in hospitals. To help combat this growing healthcare concern, hospitals need to employ more strict infection control measures, implement better antimicrobial stewardship policies, and do more active surveillance to monitor and control the potential outbreak of resistant organisms

Downloads

Download data is not yet available.

References

Parascandalo FA, Zarb P, Tartari E, Lacej D, Bitincka S, Manastirliu O, Nika D, Borg MA. Carriage of multidrug-resistant organisms in a tertiary university hospital in Albania—a point prevalence survey. Antimicrobial Resistance & Infection Control. 2016 Aug 5;5(1):29.

2. Huebner NO, Dittmann K, Henck V, Wegner C, Kramer A, Action Group Infection Prevention (AGIP). Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: Results from a nationwide one-day point prevalence of 329 German hospitals. BMC infectious diseases. 2016 Sep 2;16(1):467.

3. Puzi CP, de Almeida NF, de Almeida Leão D, de Souza DF, Baptista AB. Prevalence of multi-resistant bacteria, environmental contamination, and routine practices in a public hospital. Research, Society and Development. 2022 Oct 1;11(13):e142111335020-.

4. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India. 2010 Dec 1;58(Suppl):32-6.

5. Giufrè M, Ricchizzi E, Accogli M, Barbanti F, Monaco M, de Araujo FP, Farina C, Fazii P, Mattei R, Sarti M, Barozzi A. Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study. Clinical microbiology and infection. 2017 Dec 1;23(12):961-7.

6. Qureshi S, Maria N, Zeeshan M, Irfan S, Qamar FN. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study. BMC Infectious Diseases. 2021 Jun 9;21(1):547.

7. Jans B, Schoevaerdts D, Huang TD, Berhin C, Latour K, Bogaerts P, Nonhoff C, Denis O, Catry B, Glupczynski Y. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013 May 30;8(5):e64908.

8. Decker BK, Lau AF, Dekker JP, Spalding CD, Sinaii N, Conlan S, Henderson DK, Segre JA, Frank KM, Palmore TN. Healthcare personnel intestinal colonization with multidrug-resistant organisms. Clinical Microbiology and Infection. 2018 Jan 1;24(1):82-e1.

9. Kim HJ, Na SW, Alodaini HA, Al-Dosary MA, Nandhakumari P, Dyona L. Prevalence of multidrug-resistant bacteria associated with polymicrobial infections. Journal of Infection and Public Health. 2021 Dec 1;14(12):1864-9.

10. Bhat R, Bhandary A, Karicheri , Palakki G, Uday M. Antibody-Drug Conjugates: Advances and Applications in Targeted Cancer Therapies. Oral Sphere J. Dent. Health Sci. 2025;1(2):63-72. doi: 10.63150/osjdhs.2025.3

11. Safdar N, Sengupta S, Musuuza JS, Juthani-Mehta M, Drees M, Abbo LM, Milstone AM, Furuno JP, Varman M, Anderson DJ, Morgan DJ. Status of the prevention of multidrug-resistant organisms in international settings: a survey of the Society for Healthcare Epidemiology of America research network. infection control & hospital epidemiology. 2017 Jan;38(1):53-60.

12. Latour K, Huang TD, Jans B, Berhin C, Bogaerts P, Noel A, Nonhoff C, Dodémont M, Denis O, Ieven M, Loens K. Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015. PloS one. 2019 Mar 28;14(3):e0214327.

13. Jia XQ, Pang F, Chen JZ, Jiang LX. Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012–December 2013). Pathologie Biologie. 2015 Feb 1;63(1):21-3.

14. Messi P, Sabia C, Anacarso I, Condò C, Iseppi R, Stefani S, de Niederhausern S, Bondi M. Prevalence of multi-drug-resistant (MDR) bacteria in air samples from indoor and outdoor environments. Aerobiologia. 2015 Sep;31(3):381-7.

15. Mshana SE, Kamugisha E, Mirambo M, Chakraborty T, Lyamuya EF. Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC research notes. 2009 Mar 26;2(1):49.

16. Chen H, Au KM, Hsu KE, Lai CK, Myint J, Mak YF, Lee SY, Wong TY, Tsang NC. Multidrug-resistant organism carriage among residents from residential care homes for the elderly in Hong Kong: a prevalence survey with stratified cluster sampling. Hong Kong Medical Journal. 2018 Aug 1;24(4):350.

17. Baig K, Din SM, Elkhizzi NA, AlNakhli DJ. Incidence of hospital acquired multidrug resistant organisms in a tertiary care facility. J Infect Dis Epidemiol. 2015;1(1):1.

18. Diop M, Bassoum O, Ndong A, Wone F, Ghogomu Tamouh A, Ndoye M, Youbong T, Mbacké Daffé SM, Radji RO, Gueye MW, Lakhe NA, Fall B, Ba PS, Faye A. Prevalence of multidrug-resistant bacteria in healthcare and community settings in West Africa: systematic review and meta-analysis. BMC Infect Dis. 2025 Feb 28;25(1):292. doi: 10.1186/s12879-025-10562-w. PMID: 40022011; PMCID: PMC11871699.

19. Olaitan MO, Orababa OQ, Shittu RB, Obunukwu GM, Kade AE, Arowolo MT, Oyediran AA, Yusuff RA. Prevalence of ESBL-producing Escherichia coli in sub-Saharan Africa: A meta-analysis using a One Health approach. One Health. 2025 Jun 2;20:101090. doi: 10.1016/j.onehlt.2025.101090. PMID: 40529906; PMCID: PMC12172985.

20. Tobin EH, Jogu P, Koirala J. Methicillin-Resistant Staphylococcus aureus. [Updated 2025 Dec 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:

21. Serra-Burriel M, Keys M, Campillo-Artero C, Agodi A, Barchitta M, Gikas A, Palos C, López-Casasnovas G. Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS One. 2020 Jan 10;15(1):e0227139. doi: 10.1371/journal.pone.0227139. PMID: 31923281; PMCID: PMC6953842

Downloads

Published

2026-01-27

How to Cite

1.
Almutairi FA, Alghamdi FS, Almutairi OM, Alotaibi NF, Al-Mutairi AF, Linjawi EH. Prevalence of Multidrug-Resistant Organisms in Hospital Samples: A Microbiology Lab Survey. J Neonatal Surg [Internet]. 2026 Jan. 27 [cited 2026 May 24];15(1):45-52. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9916

Issue

Vol. 15 No. 1 (2026): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.